Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.41 |
| ▸ | MLYCD | O95822 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.41 |
| ▸ | ABAT | P80404 | 1/20 | 0.41 |
| ▸ | BCL2 | P10415 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1010125 | 0.94 | CYP2A6 (0.64) | CYP2A6ALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL6853611 | 0.88 | ALDH1A1 (0.64) | CYP2A6ALDH1A1HPGDL3MBTL1TYR | |
| SCHEMBL8469408 | 0.85 | CYP2A6 (1.00) | CYP2A6ALDH1A1SMN1; SMN2TDP1TYR | |
| SCHEMBL29171 | 0.85 | — | — | |
| SCHEMBL17508287 | 0.85 | CYP2A6 (0.52) | CYP2A6ALDH1A1MAPTHPGDNPSR1 | |
| P-Xylene SCHEMBL10939332 | 0.85 | CYP2A6 (1.00) | CYP2A6ALDH1A1SMN1; SMN2TDP1TYR | |
| Diphenylsulfane SCHEMBL28950400 | 0.85 | CYP2A6 (0.57) | CYP2A6ALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL586330 | 0.83 | CYP2A6 (0.94) | CYP2A6ALDH1A1SMN1; SMN2TDP1TYR | |
| SCHEMBL586152 | 0.83 | CYP2A6 (0.94) | CYP2A6ALDH1A1SMN1; SMN2TDP1TYR | |
| Hydrochloric Acid SCHEMBL14686576 | 0.83 | CYP2A6 (0.94) | CYP2A6ALDH1A1SMN1; SMN2TDP1TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE38425-E1 | ANTICONVULSANTS ADMINISTERED ORALLLY | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES, INC. (CA) | 2004-02-10 | — | — | US | claimed |
| EP-0836591-B1 | SEMICARBAZONES HAVING CNS ACTIVITY AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME | UNIV SASKATCHEWAN (CA) | 2001-09-26 | — | — | EP | claimed |
| US-5741818-A | ANTICONVULSANTS | UNIVERSITY OF SASKATCHEWAN (CA) | 1998-04-21 | — | — | US | claimed |
| CN-115179545-B | Compositions and articles for additive manufacturing and methods of use thereof | 斯特拉塔西斯公司 | 2024-12-24 | — | — | CN | disclosed |
| CN-118829493-A | Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking | 锡克拜控股有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-115179544-A | Compositions and articles for additive manufacturing and methods of use thereof | 科思创(荷兰)有限公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-115179545-A | Compositions and articles for additive manufacturing and methods of use thereof | 科思创(荷兰)有限公司 | 2022-10-14 | — | — | CN | disclosed |
| US-11427536-B2 | Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2022-08-30 | — | — | US | disclosed |
| CN-111526977-B | Compositions and articles for additive manufacturing and methods of use thereof | 科思创(荷兰)有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114341732-A | Liquid hybrid uv/vis radiation curable resin compositions for additive manufacturing | 科思创(荷兰)有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-108027558-B | Liquid, hybrid uv/vis radiation curable resin compositions for additive fabrication | 科思创(荷兰)有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-108472834-B | Improved antimony-free radiation curable compositions for additive fabrication and their use in investment casting processes | 帝斯曼知识产权资产管理有限公司 | 2021-05-25 | — | — | CN | disclosed |
| CN-107636025-B | Liquid, hybrid UV/visible radiation curable resin compositions for additive fabrication | 帝斯曼知识产权资产管理有限公司 | 2021-02-02 | — | — | CN | disclosed |
| CN-111526977-A | Compositions and articles for additive manufacturing and methods of use thereof | 帝斯曼知识产权资产管理有限公司 | 2020-08-11 | — | — | CN | disclosed |
| CN-104345562-B | Low viscosity liquid radiation curable dental aligner mold resin composition for additive manufacturing | 帝斯曼知识产权资产管理有限公司 | 2020-04-24 | — | — | CN | disclosed |
| US-20180370911-A1 | PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS | U.S. DEPARTMENT OF ENERGY | 2018-12-27 | — | — | US | disclosed |
| WO-2016019588-A1 | OXACAZONE COMPOUNDS TO TREAT CLOSTRIDIUM DIFFICILE | THE BROAD INSTITUTE, INC. (US) | 2016-02-11 | — | — | WO | disclosed |
| US-8357737-B2 | Polyarylene sulfide composition | TOSOH CORPORATION (JP) | 2013-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180370911-A1 | PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS | TST, CBS, CRY2 | CYP2A6 249/4885ALDH1A1 716/4885MAPT 3163/4885 |
| US-11427536-B2 | Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods | TST, CBS, CRY2 | CYP2A6 249/4885ALDH1A1 716/4885MAPT 3163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.